A carregar...

Glycosylation of MUC1 influences the binding of a therapeutic antibody by altering the conformational equilibrium of the antigen

In cancer cells, the glycoprotein Mucin 1 (MUC1) undergoes abnormal, truncated glycosylation. The truncated glycosylation exposes cryptic peptide epitopes that can be recognized by antibodies. Since these immunogenic regions are cancer specific, they represent ideal targets for therapeutic antibodie...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Glycobiology
Main Authors: Movahedin, Mohammadreza, Brooks, Teresa M, Supekar, Nitin T, Gokanapudi, Naveen, Boons, Geert-Jan, Brooks, Cory L
Formato: Artigo
Idioma:Inglês
Publicado em: Oxford University Press 2017
Assuntos:
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC5881634/
https://ncbi.nlm.nih.gov/pubmed/28025250
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/glycob/cww131
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!